Another study also reported that polymorphisms induce high angiotensinogen and TGF-β1, the most abundant isoform of TGF-β, are associated with advanced hepatic fibrosis in patients with NAFLD [34]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.